Alzheimer's drug lecanemab receives accelerated approval amid safety concerns – CNN
Business News
- Alzheimer’s drug lecanemab receives accelerated approval amid safety concerns CNN
- New Alzheimer’s Drug Leqembi Will Be Out of Reach for Most Patients The Wall Street Journal
- EXPLAINER: New drug slows Alzheimer’s but comes with caveats The Associated Press – en Español
- FDA greenlights new Alzheimer’s drug amid safety concerns NBC News
- Alzheimer’s drug granted accelerated approval by FDA. These are the risks CNN
Source: Business News